In a colon-26 tumor model, oral administration of YM-2A induced IFN-γ expression by CD4+ T cells in the spleen, and CD8+ T cells in the spleen and TDLNs (Fig 5D and 5E). This evidence concerns the gene CD4 and neoplasm.